skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 6
Patent #:
10053689
Issue Dt:
08/21/2018
Application #:
14700938
Filing Dt:
04/30/2015
Publication #:
20160024498
Pub Dt:
01/28/2016
Inventors:
Kevin Fitzgerald, Akin Akinc, Maria Frank-Kamenetsky, Martin A. Maier
Title:
METHODS FOR INCREASING EFFICACY OF LIPID FORMULATED siRNA
Assignment: 1
Reel/Frame:
040819/0004Recorded: 12/05/2016Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
FITZGERALD, KEVIN
Exec Dt:
04/18/2012
AKINC, AKIN
Exec Dt:
05/01/2012
MAIER, MARTIN A.
Exec Dt:
04/18/2012
FRANK-KAMENETSKY, MARIA
Exec Dt:
04/19/2012
Assignee:
ALNYLAM PHARMACEUTICALS, INC.
300 THIRD STREET
CAMBRIDGE, MASSACHUSETTS 02142
Correspondent:
VIKSNINS HARRIS & PADYS, PLLP
7851 METRO PARKWAY
SUITE 325
BLOOMINGTON, MN 55425
Assignment: 2
Reel/Frame:
040531/0036Recorded: 12/05/2016Pages: 12
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
ALNYLAM PHARMACEUTICALS, INC.
Exec Dt:
12/05/2012
Assignee:
TEKMIRA PHARMACEUTICALS CORPORATION
100-8900 GLENLYON PARKWAY
BURNABY, BRITISH COLUMBIA, CANADA V5J 5J8
Correspondent:
VIKSNINS HARRIS & PADYS, PLLP
7851 METRO PARKWAY
SUITE 325
BLOOMINGTON, MN 55425
Assignment: 3
Reel/Frame:
040531/0055Recorded: 12/05/2016Pages: 14
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
ALNYLAM PHARMACEUTICALS, INC.
Exec Dt:
12/05/2012
Assignee:
TEKMIRA PHARMACEUTICALS CORPORATION
100-8900 GLENLYON PARKWAY
BURNABY, BRITISH COLUMBIA, CANADA V5J 5J8
Correspondent:
VIKSNINS HARRIS & PADYS, PLLP
7851 METRO PARKWAY
SUITE 325
BLOOMINGTON, MN 55425
Assignment: 4
Reel/Frame:
040531/0005Recorded: 12/05/2016Pages: 2
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
TEKMIRA PHARMACEUTICALS CORPORATION
Exec Dt:
07/31/2015
Assignee:
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY
BURNABY, BRITISH COLUMBIA, CANADA V5J 5J8
Correspondent:
VIKSNINS HARRIS & PADYS, PLLP
7851 METRO PARKWAY
SUITE 325
BLOOMINGTON, MN 55425
Assignment: 5
Reel/Frame:
046406/0881Recorded: 06/21/2018Pages: 3
Conveyance:
MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignors:
PROTIVA BIOTHERAPEUTICS INC.
Exec Dt:
01/01/2018
Newly Merged Entity Data
ARBUTUS BIOPHARMA CORPORATION
Exec Dt:
01/01/2018
Newly Merged Entity's New Name:
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY
BURNABY, BRITISH COLUMBIA, CANADA V5J 5J8
Correspondent:
VIKSNINS HARRIS PADYS MALEN LLP
7851 METRO PARKWAY
SUITE 325
BLOOMINGTON, MN 55425
Assignment: 6
Reel/Frame:
046640/0764Recorded: 07/27/2018Pages: 4
Conveyance:
MERGER AND CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignors:
PROTIVA BIOTHERAPEUTICS INC.
Exec Dt:
01/01/2018
Newly Merged Entity Data
ARBUTUS BIOPHARMA CORPORATION
Exec Dt:
01/01/2018
Newly Merged Entity's New Name:
ARBUTUS BIOPHARMA CORPORATION
100-8900 GLENLYON PARKWAY
BURNABY, BRITISH COLUMBIA, CANADA V5J 5J8
Correspondent:
VIKSNINS HARRIS PADYS MALEN LLP
7851 METRO PARKWAY
SUITE 325
BLOOMINGTON, MN 55425

Search Results as of: 06/03/2024 09:24 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT